Initiator Pharma A/S (OSTO:INIT) EV-to-EBIT : -16.15 (As of Jun. 14, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma A/S EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Initiator Pharma A/S's Enterprise Value is kr549.07 Mil. Initiator Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-34.01 Mil. Therefore, Initiator Pharma A/S's EV-to-EBIT for today is -16.15.

The historical rank and industry rank for Initiator Pharma A/S's EV-to-EBIT or its related term are showing as below:

OSTO:INIT' s EV-to-EBIT Range Over the Past 10 Years
Min: -24.9 Med: 0 Max: 0
Current: -16.15

OSTO:INIT's EV-to-EBIT is ranked worse than
100% of 425 companies
in the Biotechnology industry
Industry Median: 9.71 vs OSTO:INIT: -16.15

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Initiator Pharma A/S's Enterprise Value for the quarter that ended in Mar. 2024 was kr481.58 Mil. Initiator Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-34.01 Mil. Initiator Pharma A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -7.06%.

Initiator Pharma A/S EV-to-EBIT Historical Data

The historical data trend for Initiator Pharma A/S's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Initiator Pharma A/S EV-to-EBIT Chart

Initiator Pharma A/S Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-13.54

-7.95

-10.27

-4.51

-11.63

Initiator Pharma A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-5.57	-7.61	-8.75	-11.63	-14.16

Competitive Comparison of Initiator Pharma A/S's EV-to-EBIT

For the Biotechnology subindustry, Initiator Pharma A/S's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Initiator Pharma A/S's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma A/S's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Initiator Pharma A/S's EV-to-EBIT falls into.

Initiator Pharma A/S EV-to-EBIT Calculation

Initiator Pharma A/S's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	549.074	/	-34.006
	=	-16.15

Initiator Pharma A/S's current Enterprise Value is kr549.07 Mil.
Initiator Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-34.01 Mil.

Initiator Pharma A/S (OSTO:INIT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Initiator Pharma A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-34.006	/	481.58109
	=	-7.06 %

Initiator Pharma A/S's Enterprise Value for the quarter that ended in Mar. 2024 was kr481.58 Mil.
Initiator Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-34.01 Mil.

Initiator Pharma A/S EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Initiator Pharma A/S's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Initiator Pharma A/S (OSTO:INIT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma A/S (OSTO:INIT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200

Website

https://www.initiatorpharma.com

Initiator Pharma A/S is a clinical Stage Life Science company engaged in the research and development of various drugs targeting medical needs within the central and peripheral nervous system. The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men. Its MRI drug candidates also include IPDP2015 for the treatment of depression; and IPNP2015 to treat neuropathic pain.

Initiator Pharma A/S (OSTO:INIT) Headlines

No Headlines